$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Which patients is Lorlatinib mainly suitable for? Scope of application of targeted therapy and genetic testing requirements
2026-02-01 22:25:32
Check Details
How should fostatinib be taken? What is the correct usage and dosage?
2026-02-01 22:25:32
Check Details
What is the usage and dosage of bosutinib? What is the correct method and dosage of taking it?
2026-02-01 22:25:32
Check Details
Who is recommended to use Militizumab? What patient groups is it suitable for?
2026-02-01 22:25:32
Check Details
How long does it take for Lorlatinib to take effect? Clinical trial data and patient feedback
2026-02-01 22:25:32
Check Details
What drug is pomalidomide? What are its main ingredients and functions?
2026-02-01 22:25:32
Check Details
What drugs may lapatinib interact with? What medications should be avoided when using them?
2026-02-01 22:25:32
Check Details
Are there any special precautions when using filgotinib?
2026-02-01 22:25:32
Check Details
How effective is lorlatinib (lorlatinib) in treating lung cancer? Domestic and foreign research data and patient survival analysis
2026-02-01 22:25:32
Check Details
What precautions should be taken when using trientine? What aspects do patients need to pay special attention to?
2026-02-01 22:25:32
Check Details
Can fostatinib prevent breast cancer recurrence or metastasis? How effective is it in breast cancer treatment?
2026-02-01 22:25:32
Check Details
What is the difference between bosutinib and imatinib? What are the differences in their mechanisms of action and efficacy?
2026-02-01 22:25:32
Check Details
1
2
...
1487
1488
1489
1490
1491
1492
1493
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
2
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
3
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
4
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
5
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
6
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
7
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
8
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
9
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
10
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
11
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
12
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment